The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 03, 2018

Filed:

Dec. 16, 2010
Applicants:

Daniel S. Kohane, Newton, MA (US);

Hila Epstein-barash, Newton, MA (US);

Mark A. Borden, Boulder, CO (US);

Inventors:

Daniel S. Kohane, Newton, MA (US);

Hila Epstein-Barash, Newton, MA (US);

Mark A. Borden, Boulder, CO (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61M 37/00 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 41/00 (2006.01); A61K 9/06 (2006.01);
U.S. Cl.
CPC ...
A61M 37/0069 (2013.01); A61K 9/0009 (2013.01); A61K 9/107 (2013.01); A61K 41/0028 (2013.01); A61K 9/06 (2013.01); A61L 2300/602 (2013.01); A61L 2300/62 (2013.01); A61L 2300/626 (2013.01); A61L 2400/06 (2013.01); A61M 37/0092 (2013.01);
Abstract

Injectable or implantable drug delivery systems providing on-demand ultrasound-triggered drug release and methods for controlling the release of drug in a patient are provided herein. The on-demand drug delivery systems contain a drug depot and a drug encapsulated in an encapsulating material, where the encapsulating material is different from the depot. In the preferred embodiment, the depot also contains microbubbles that encapsulate one or more gases. The microbubbles enhance the drug release when ultrasound is applied compared to the same system in the absence of microbubbles. In a preferred embodiment, the drug delivery system, contains an encapsulating material, preferably liposomes, a drug to be delivered, microbubbles, and at least two hydrogel-forming precursor components. Following injection or implantation, the patient can control the time, location and dosage released by administering ultrasound.


Find Patent Forward Citations

Loading…